Appraised Potential Production definition

Appraised Potential Production means the total potential production, as determined by AFSC, of an unharvested crop or a crop Put to Another Use.
Sample 1Sample 2Sample 3
Appraised Potential Production means in addition to the definition under the Terms and Conditions, when grain corn is put up to silage, grain corn yields will be deemed to be equal to 40 percent of the Silage dry matter weight.
Sample 1Sample 2
Appraised Potential Production means the total potential production, as determined by AFSC, of an unharvested hay crop or a hay crop Put to Another Use.
Sample 1Sample 2

Examples of Appraised Potential Production in a sentence

  • If an Appraised Potential Production of not less than 50 percent of Coverage by crop will be assessed, then Crop Premium will be charged on the full acres.

  • It also provides relief and humanitarian assistance during natural calamities which from time to time afflict the country.

  • AFSC will apply, in its discretion, the Appraised Potential Production, and a Grade on the Appraised Potential Production if the Insured has not completed harvest on or before October 15.

  • Where the Insured has, on or before June 20 any year, incurred a loss from Designated Perils on one or more parcels of seeded land and meets minimum acreage requirements and AFSC releases and confirms the damaged acres as per Part I Section T Insured Crop Put to Another Use, then either (i) the reseeding Indemnity will be determined as specified by AFSC for each crop on damaged acres; or (ii) an Appraised Potential Production of not less than fifty (50) percent of Coverage by crop will be assessed.

  • If the released acres are not seeded to an elected annual crop, the acres will remain insured under the Hay subscription; AFSC will deem the Appraised Potential Production to be zero, and the uninsured loss to be equal to Coverage.

  • If an Insured Crop is eligible for the Winterkill Provision and is Put to Another Use due to winterkill, the Appraised Potential Production will be an amount no less than one-half of Coverage on the acres Put to Another Use provided the acreage was first assessed by AFSC.

  • When the Insured has accepted the Appraised Potential Production on any portion of an Insured Crop, no further appraisal will be made on that portion unless, and at the sole discretion of AFSC, substantial damage occursbefore the Insured can put the crop to some other use within a reasonable period of time.

  • Becky Callister, Principal of Delta Middle School, met with the Membersof the Board to present the following items to the Board of Education: 1.

  • If an Insured Crop is eligible for the Winterkill Provision and is Put to Another Use due to winter-kill, the Appraised Potential Production, regarded as being of the Designated Grade, will be an amount no less than one-half of the Coverage on the acres Put to Another Use provided the acreage was first assessed by AFSC.

  • Adaptation, like social policy in JSP’s name, is forward looking and deals with both intangible goods and capacities that may be of no value until tomorrow.

Related to Appraised Potential Production

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Commercial Production means the operation of the Property or any portion thereof as a producing mine and the production of mineral products therefrom (excluding bulk sampling, pilot plant or test operations);

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Attack directed against any civilian population means a course of conduct involving the multiple commission of acts referred to in paragraph 1 against any civilian population, pursuant to or in furtherance of a State or organizational policy to commit such attack;

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”

  • The Material/ Product means all the materials along with the accessories which the contractor is required to supply to the Bank under the Contract.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Commercial Product means any such product as defined in FAR 2.101.

  • Material Project means the construction or expansion of any capital project of the Borrower or any of its Subsidiaries, the aggregate capital cost of which exceeds $25,000,000.

  • Peak tube potential means the maximum value of the potential difference across the x-ray tube during an exposure.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Sewage sludge fee weight means the weight of sewage sludge, in dry U.S. tons, excluding admixtures such as liming materials or bulking agents. Annual sewage sludge fees, as per section 3745.11(Y) of the Ohio Revised Code, are based on the reported sludge fee weight for the most recent calendar year.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Commencement of Commercial Production means the first occurrence of Commercial Production in an Area.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.